Rational drug design: development of angiogenesis inhibitors targeting VEGF and TI...
Molecular mechanisms of angiogenesis and vascular heterogeneity
Characterization of peptides that interact with receptor tyrosine kinase VEGFR-3
Peptide and antibody phage display: a combination for Engineering antibodies again...
Structural basis for the interaction of a new compound inhibitor of angiogenesis w...
Development of peptidomimetic compounds for the treatment of retinopathy
Inflamatory response in spinal cord injury treated with VEGF and PDGF